Literature DB >> 27578200

Evaluation of insulin-like growth factor-1, total thyroxine, feline pancreas-specific lipase and urinary corticoid-to-creatinine ratio in cats with diabetes mellitus in Switzerland and the Netherlands.

Sandra Schaefer1, Hans S Kooistra2, Barbara Riond3, Jan S Suchodolski4, Jörg M Steiner4, Marrit Prins2, Eric Zini1,5,6, Claudia E Reusch1.   

Abstract

Objectives The aim of the study was to evaluate circulating insulin-like growth factor-1 (IGF-1), feline pancreas-specific lipase (fPLI) and total thyroxine (TT4) concentrations and urinary corticoid-to-creatinine ratio (UCCR) as indicators for the prevalence of acromegaly, pancreatitis, hyperthyroidism and hypercortisolism in cats with diabetes mellitus. Methods Blood and urine samples were collected from diabetic cats treated in primary care clinics in Switzerland and the Netherlands. Standardised questionnaires and physical examination forms provided clinical information from owners and veterinarians. Laboratory testing included serum biochemistry profile analysis and measurement of circulating fructosamine, IGF-1, fPLI, and TT4 concentrations and UCCR. CT of the pituitary gland was performed using a multidetector computed tomography scanner. Results Blood samples were available from 215 cats and urine samples were collected at home from 117 cats. Age ranged from 2-18 years (median 12 years) and body weight from 2.7-12.3 kg (median 5.5 kg). Sixty-five percent of the cats were castrated male and 35% were female (33% spayed); 82% were domestic shorthair cats. Eighty percent of cats received a porcine insulin zinc suspension, 19.5% insulin glargine and 0.5% a human neutral protamine hagedorn insulin. Thirty-six of 202 (17.8%) cats had IGF-1 concentrations >1000 ng/ml. Serum fPLI, and TT4 concentrations and UCCR were increased in 86/196 (43.9%), 9/201 (4.5%) and 18/117 cats (15.3%), respectively. Prevalence did not differ between countries. Conclusions Hyperthyroidism is rare, whereas increased fPLI concentration, possibly reflecting pancreatitis, is common in diabetic cats. The high UCCR may reflect activation of the hypothalamus-pituitary-adrenal axis, which also occurs in diabetic humans. The percentage of cats with increased IGF-1 was high but lower than reported in recent studies.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27578200     DOI: 10.1177/1098612X16664390

Source DB:  PubMed          Journal:  J Feline Med Surg        ISSN: 1098-612X            Impact factor:   2.015


  6 in total

1.  Pasireotide Long-Acting Release Treatment for Diabetic Cats with Underlying Hypersomatotropism.

Authors:  R Gostelow; C Scudder; S Keyte; Y Forcada; R C Fowkes; H A Schmid; D B Church; S J M Niessen
Journal:  J Vet Intern Med       Date:  2017-02-01       Impact factor: 3.333

2.  The Effect of Supplemental Concentrate Feeding on the Morphological and Functional Development of the Pancreas in Early Weaned Yak Calves.

Authors:  Yang Jiao; Shujie Liu; Yanan Zhou; Deyu Yang; Jilan Li; Zhanhong Cui
Journal:  Animals (Basel)       Date:  2022-09-26       Impact factor: 3.231

3.  Diabetes mellitus remission in three cats with hypersomatotropism after cabergoline treatment.

Authors:  Diego D Miceli; Patricia N Vidal; Gustavo A Pompili; Víctor A Castillo; Elber A Soler Arias; Stijn Jm Niessen
Journal:  JFMS Open Rep       Date:  2021-05-31

4.  Serum Fructosamine Concentration in Uncontrolled Hyperthyroid Diabetic Cats Is within the Population Reference Interval.

Authors:  Arnon Gal; Brie Trusiano; Adrienne F French; Nicolas Lopez-Villalobos; Amy L MacNeill
Journal:  Vet Sci       Date:  2017-03-15

5.  Efficacy of hypophysectomy for the treatment of hypersomatotropism-induced diabetes mellitus in 68 cats.

Authors:  Joe Fenn; Patrick J Kenny; Christopher J Scudder; Katarina Hazuchova; Ruth Gostelow; Robert C Fowkes; Yaiza Forcada; David B Church; Stijn J M Niessen
Journal:  J Vet Intern Med       Date:  2021-02-24       Impact factor: 3.333

6.  Evaluation of hypophysectomy for treatment of hypersomatotropism in 25 cats.

Authors:  Kirsten L van Bokhorst; Sara Galac; Hans S Kooistra; Chiara Valtolina; Federico Fracassi; Dan Rosenberg; Björn P Meij
Journal:  J Vet Intern Med       Date:  2021-02-23       Impact factor: 3.333

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.